Related Experiment Video
Updated: Aug 9, 2026
07:44
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
Published on: September 14, 2019
Integrated dystrophin analysis using immunocytochemical, biochemical and genetic techniques
L V Nicholson1, M A Johnson, K E Davies
1Muscular Dystrophy Group Research Laboratories, Newcastle General Hospital, Newcastle upon Tyne, U.K.
Basic and Applied Histochemistry
|January 1, 1990
Summary
Investigating X-linked muscular dystrophy involves combining immunocytochemistry, immunoblotting, and DNA analysis. This approach helps identify the specific defective gene product causing the condition.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Immunocytochemistry is a valuable technique for diagnosing clinical issues.
- Complementary methods like immunoblotting and DNA analysis enhance diagnostic capabilities.
Purpose of the Study:
- To demonstrate the combined use of immunocytochemistry, immunoblotting, and DNA analysis.
- To investigate the defective gene product in X-linked muscular dystrophy.
Main Methods:
- Utilizing immunocytochemistry for protein localization.
- Employing immunoblotting for protein identification and quantification.
- Applying DNA analysis for genetic defect identification.
Main Results:
- The study presents a case example integrating these three techniques.
- The defective gene product in X-linked muscular dystrophy was successfully investigated.
Conclusions:
- The synergistic application of immunocytochemistry, immunoblotting, and DNA analysis is effective for elucidating complex genetic disorders.
- This integrated approach aids in understanding the molecular basis of diseases like X-linked muscular dystrophy.
